Catalyst Wire Dossier Catalyst Wire Dossier

Timolol Maleate Ophthalmic Gel Forming Solution 0.25%

timolol maleate ophthalmic gel forming solution 0.25% · NorthStar RxLLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Timolol Maleate Ophthalmic Gel Forming Solution 0.25%, covering 2020-10-22 to 2022-09-22. Get the full timeline:

Most recent: FDA Approved: TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25% — Original Application (NorthStar RxLLC)

See pricing